Acadia shares rise on study success for Rett syndrome drug
No treatments are available for Rett syndrome, although a number of companies, including Acadia, aim to change that.
Acadia's drug is a synthetic version of a protei...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement